This toolbox was developed for the World Health Organisation COVID-19 Research Roadmap as a joint initiative between the social science and ethics working groups. 

Community engagement is widely promoted in health research to strengthen the protection of, respect for, and empowerment of participant communities, and to improve the relevance and quality of research. Community Advisory Boards/Groups (CAB/Gs), or variants, are the most widely documented structures supporting community engagement.  Here the WHO Task Force on Good Participatory Practices in Emerging Pathogens (GPP-EP) shares information on establishing and working with different types of advisory groups in the context of COVID-19 clinical studies.  

Download the toolbox for Working with Community Advisory Boards for COVID-19 related clincial studies HERE

This article is part of our theme area on Good Participatory Practice in COVID-19 Research 

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License

Also By

World Health Organisation, Mesh Editorial Team

Categories

Epidemics (Mesh)  Community Advisory Boards (Mesh)  Evaluating Community Advisory Boards (Mesh)  Trial Design (Mesh)  Trial Design (Mesh-Guides)  Trial Conduct (Mesh)  Trial Conduct (Mesh-Guides)  Community Advisory Boards (Mesh-Guides)  Mesh Guides and Tools  Epidemics - programme design - biomedical (Mesh)  Epidemics - implementation - during - biomedical (Mesh)  COVID-19 (Mesh)  GPP - Trust (Mesh)  GPP - Lifecycle All (Mesh)  GPP - Lifecycle Study Design (Mesh)  GPP - Lifecycle Before (Mesh)  GPP - Lifecycle During (Mesh)  GPP - All (Mesh)  

Tags

Reply

Please Sign in (or Register) to view further.